Skip to main content

Table 2 Measurements of urinary GAGs under weekly and biweekly dose regimens

From: Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series

   Fold increase (mg/GAG/mmol creatinine) above reference range;
N = within normal limits
Patient Phenotype T1 T2 T3
1 H 5 N N
2 H 9 N N
3 H 19 2.3 3.8
5 HS 16 N N
6 HS 43 N N
7 HS NA 2.9 N
8 HS 4.4 N N
9 HS 9 N N
10 HS 23 N N
11 HS 9.6 N N
12 HS 4.8 1.2 N
14 S 5 1.2 2.9
16 S 7.9 2.4 1.8
17 S 148 1.1 N
18 S 3.7 N N
19 S 1.7 2.1 1.2
20 S 2.7 N 1.2